The FDA's approval of a generic version of the abortion pill Mifepristone marks a significant development, sparking intense debate among abortion rights advocates and opponents.
The dismissal of an N.I.H. scientist who filed a whistle-blower complaint raises concerns about political interference in vaccine research and the independence of public health institutions.
The introduction of the TrumpRx website and an associated Pfizer deal aims to reduce Medicaid prescription drug prices by enabling consumers to purchase directly from manufacturers.